These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8886078)

  • 41. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
    Krieg M; Weisser H; Tunn S
    Verh Dtsch Ges Pathol; 1993; 77():19-24. PubMed ID: 7511279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pathophysiology of benign prostatic hyperplasia].
    Frick J
    Wien Med Wochenschr; 1996; 146(8):158-60. PubMed ID: 8767399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphological and quantitative analyses of intraductal dysplasia of the prostate.
    Montironi R; Scarpelli M; Sisti S; Braccischi A; Mariuzzi GM
    Anal Cell Pathol; 1990 Sep; 2(5):277-85. PubMed ID: 1703435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.
    Prakash K; Pirozzi G; Elashoff M; Munger W; Waga I; Dhir R; Kakehi Y; Getzenberg RH
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7598-603. PubMed ID: 12032329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autopsy study of prostatic weight and lesions in LUTH: a 12 month prospective study.
    Erinomo OO; Anunobi CC; Orah NO
    Nig Q J Hosp Med; 2013; 23(2):85-9. PubMed ID: 24579501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Origin and evolution of benign prostatic enlargement.
    McNeal JE
    Invest Urol; 1978 Jan; 15(4):340-5. PubMed ID: 75197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathology of benign prostatic hyperplasia. Insight into etiology.
    McNeal J
    Urol Clin North Am; 1990 Aug; 17(3):477-86. PubMed ID: 1695776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative changes in the morphology of the aging canine prostate.
    Zirkin BR; Strandberg JD
    Anat Rec; 1984 Feb; 208(2):207-14. PubMed ID: 6200008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
    Shapiro E; Becich MJ; Hartanto V; Lepor H
    J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia.
    Wu F; Ding S; Li X; Wang H; Liu S; Wu H; Bi D; Ding K; Lu J
    Oncotarget; 2016 Mar; 7(11):12053-62. PubMed ID: 26919249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
    Viglione MP; Potter S; Partin AW; Lesniak MS; Epstein JI
    Hum Pathol; 2002 Aug; 33(8):796-800. PubMed ID: 12203211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Benign prostate hyperplasia induced by urogenital sinus implantation in rats: a histomorphological study].
    Shen Q; Zhu Z; Zhu L; Yuan M
    Zhonghua Nan Ke Xue; 2012 Aug; 18(8):703-9. PubMed ID: 22934515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Histologic components of benign prostatic hypertrophy (bph) in relation to the androgen-estrogen status (author's transl)].
    Seppelt U; Buhl K; Drews M
    Urologe A; 1978 Mar; 17(2):117-9. PubMed ID: 76360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study.
    DiBello JR; Ioannou C; Rees J; Challacombe B; Maskell J; Choudhury N; Kastner C; Kirby M
    BJU Int; 2016 May; 117(5):801-8. PubMed ID: 26392030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical profiles of prostatic fluid from normal and diseased prostate glands.
    Grayhack JT; Lee C; Oliver L; Schaeffer AJ; Wendel EF
    Prostate; 1980; 1(2):227-37. PubMed ID: 15619922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concentration and content of zinc in the human prostate.
    Leissner KH; Fjelkegård B; Tisell LE
    Invest Urol; 1980 Jul; 18(1):32-5. PubMed ID: 6157652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.
    Buhigas C; Warren AY; Leung WK; Whitaker HC; Luxton HJ; Hawkins S; Kay J; Butler A; Xu Y; Woodcock DJ; Merson S; Frame FM; Sahli A; Abascal F; ; Martincorena I; Bova GS; Foster CS; Campbell P; Maitland NJ; Neal DE; Massie CE; Lynch AG; Eeles RA; Cooper CS; Wedge DC; Brewer DS
    Mol Cancer; 2022 Sep; 21(1):183. PubMed ID: 36131292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
    Yoo KH; Kim SK; Chung JH; Chang SG
    Asian J Androl; 2010 Sep; 12(5):690-6. PubMed ID: 20562898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.
    Marks LS; Treiger B; Dorey FJ; Fu YS; deKernion JB
    Urology; 1994 Oct; 44(4):486-92. PubMed ID: 7524234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.